Jonas Paludo

Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium

Yucai Wang, Preetesh Jain, Frederick L. Locke et al. · Journal of Clinical Oncology · 2023 · 176 citations · Full text

Medicine, Hematology, Oncology +16

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Narjust Duma, Azzouqa Abdel-Ghani, Siddhartha Yadav et al. · The Oncologist · 2019 · 134 citations · Full text

Life Sciences, Immunology, Oncology +17

Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

Jorge J. Castillo, Gilad Itchaki, Jonas Paludo et al. · Blood · 2018 · 100 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +3

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Jonas Paludo, Jithma P. Abeykoon, Amanda Shreders et al. · Annals of Hematology · 2018 · 97 citations

Medicine, Immunology, Pharmacotherapy +6

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

Jonas Paludo, Joseph Mıkhael, Betsy LaPlant et al. · Blood · 2017 · 77 citations · Full text

Medicine, Hematology, Pharmacotherapy +11